RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

NCT07489651 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: RE104 for Injection
DRUG: Placebo

Sponsor

Reunion Neuroscience Inc